Latest Cancer Research Stories
SAN DIEGO and CHICAGO, June 30, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), the Robert H.
UT Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.
Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer.
WILLIAMSBURG, Va., June 24, 2014 /PRNewswire/ -- The Snow Companies has been named a winner in the 35th Annual Telly Awards.
PHILADELPHIA, June 24, 2014 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the inaugural class of Pew-Stewart Scholars for Cancer
Every year around 450,000 people in Germany are diagnosed with cancer.
~Company Recognized as Notable Recipient of SBIR Grants CHARLOTTESVILLE, Va., June 20, 2014 /PRNewswire/ -- HemoShear, LLC, the human disease biology company, today announced that
$3 Million NIH Grant to Fund Effort to Rescue Tissue That Would be Destroyed Charlottesville, Va.
New research study “Antibiotics Partnering Terms and Agreements” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB)
- A political dynamiter.